Skip to main content
. 2017 Mar 23;10(3):346–356. doi: 10.1016/j.tranon.2017.01.014

Supplementary Figure 2.

Supplementary Figure 2

HGSOC ROR2 stroma survival analysis. (A) Kaplan-Meier curve representing progression-free survival (PFS) of HGSOC patients with ROR2 weak (group 1, blue) and ROR2 strong (group 2, red) stroma expression. No significant trend was found. (B)Kaplan-Meier curve representing overall survival (OS) of HGSOC patients with ROR2 weak (group 1, blue) and ROR2 strong (group 2, red) stromal expression. No significant trend was found.